Skip to main content
. 2010 Mar 17;2010(3):CD002233. doi: 10.1002/14651858.CD002233.pub2

Comparison 8. Sensitivity analysis 4: EVS versus somatostatin, excluding the Escorsell's study.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Mortality 4 237 Risk Difference (M‐H, Random, 95% CI) ‐0.06 [‐0.17, 0.05]
1.1 Mortality 4 237 Risk Difference (M‐H, Random, 95% CI) ‐0.06 [‐0.17, 0.05]